Your browser doesn't support javascript.
loading
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
Maura, Francesco; Boyle, Eileen M; Coffey, David; Maclachlan, Kylee; Gagler, Dylan; Diamond, Benjamin; Ghamlouch, Hussein; Blaney, Patrick; Ziccheddu, Bachisio; Cirrincione, Anthony; Chojnacka, Monika; Wang, Yubao; Siegel, Ariel; Hoffman, James E; Kazandjian, Dickran; Hassoun, Hani; Guzman, Emily; Mailankody, Sham; Shah, Urvi A; Tan, Carlyn; Hultcrantz, Malin; Scordo, Michael; Shah, Gunjan L; Landau, Heather; Chung, David J; Giralt, Sergio; Zhang, Yanming; Arbini, Arnaldo; Gao, Qi; Roshal, Mikhail; Dogan, Ahmet; Lesokhin, Alexander M; Davies, Faith E; Usmani, Saad Z; Korde, Neha; Morgan, Gareth J; Landgren, Ola.
Afiliação
  • Maura F; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. fxm557@med.miami.edu.
  • Boyle EM; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Coffey D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Maclachlan K; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gagler D; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Diamond B; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Ghamlouch H; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Ziccheddu B; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Cirrincione A; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Chojnacka M; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Wang Y; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Siegel A; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Hoffman JE; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Kazandjian D; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Hassoun H; Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Guzman E; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mailankody S; Genome Technology Center, NYU Langone, Perlmutter Cancer Center, New York, NY, USA.
  • Shah UA; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tan C; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Scordo M; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Shah GL; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Landau H; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Chung DJ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Giralt S; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Zhang Y; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Arbini A; Hematopathology Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gao Q; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Roshal M; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dogan A; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Lesokhin AM; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Davies FE; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Usmani SZ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Korde N; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Morgan GJ; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Landgren O; Cytogenetics Laboratory, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Cancer ; 4(12): 1660-1674, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37945755

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article